Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Novartis Pharmaceuticals Corporation: 26 Drugs and 322,703 Adverse Event Reports

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Novartis Pharmaceuticals Corporation manufactures 26 drugs with a combined 322,703 adverse event reports in the FDA FAERS database. Their most reported drug is SECUKINUMAB.

26
Drugs
322,703
Combined Reports
SECUKINUMAB
Top Drug
31,368
Total Deaths
55,176
Total Hospitalizations

All Novartis Pharmaceuticals Corporation Drugs & Safety Profiles

Drug Brand Name Reports Deaths Death Rate Hosp.
SECUKINUMAB COSENTYX 151,223 6,855 4.5% 19,098
OFATUMUMAB ARZERRA 29,913 695 2.3% 3,616
RIBOCICLIB KISQALI 27,997 4,501 16.1% 6,700
DABRAFENIB Tafinlar 19,305 4,165 21.6% 5,325
TRAMETINIB DIMETHYL SULFOXIDE Mekinist 16,286 3,925 24.1% 3,438
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN PLUVICTO 10,716 1,461 13.6% 545
CANAKINUMAB Ilaris 10,462 518 5.0% 2,624
RIVASTIGMINE Exelon 9,123 2,232 24.5% 2,716
SIPONIMOD MAYZENT 8,581 196 2.3% 1,396
ALPELISIB PIQRAY 8,419 1,271 15.1% 1,705
BASILIXIMAB Simulect 6,817 1,507 22.1% 2,802
INCLISIRAN LEQVIO 6,360 176 2.8% 567
TISAGENLECLEUCEL KYMRIAH 4,229 1,232 29.1% 1,256
MIDOSTAURIN RYDAPT 2,993 694 23.2% 918
CERITINIB ZYKADIA 2,796 786 28.1% 804
ASCIMINIB SCEMBLIX 2,330 269 11.5% 426
CAPMATINIB TABRECTA 2,301 583 25.3% 388
DEFEROXAMINE Desferal 839 152 18.1% 314
BROLUCIZUMAB BEOVU 682 41 6.0% 105
BETAXOLOL Betoptic S 638 67 10.5% 261
IPTACOPAN FABHALTA 468 23 4.9% 88
CRIZANLIZUMAB ADAKVEO 126 16 12.7% 65
TRICLABENDAZOLE EGATEN 42 0 N/A 4
ARTEMETHER COARTEM 21 2 9.5% 9
REMIBRUTINIB RHAPSIDO 21 0 N/A 1
ATRASENTAN VANRAFIA 15 1 6.7% 5